-
-
-
-
-
-
-
Lilly to present oncology data at ASCO 2026 meeting
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Eli Lilly (LLY)
-
-
-
-
-
-
-
Barclays on Eli Lilly (LLY): Centessa a 'sensible tuck-in' for neuroscience division
-
-
-
-
-
-
-
Eli Lilly to acquire Orna Therapeutics for up to $2.4 billion
-
-
-
-
-
-
-
After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis
-
-
-
-
-
-
-
Breakthrough Properties partners with Eli Lilly for Philadelphia lab space
-
-
-
-
-
-
-
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
-
1,158,071 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

